1. National Referral Pathways 1.1 Standardized Criteria Develop and implement clear, disease-specific referral criteria for suspected GU cancers. For example: • Hematuria with risk factors warrants immediate referral. • Specific timelines from symptom recognition to diagnostic cystoscopy. 1.2 Referral Checklists Create mandatory checklists that must accompany referrals, including: • Imaging (CT scan) • Cytology and histopathology reports • PSA levels (for prostate evaluation) • Comprehensive medical history and comorbidity evaluation 1.3 Timelines Establish benchmarks for acceptable timeframes: • From symptom onset to first specialist visit: <2 weeks • From diagnosis to treatment initiation: <4 weeks2. Establishment of Specialized Clinics 2.1 Hematuria Clinics Following the model of breast cancer pathways, specialized hematuria clinics could provide same-day imaging, cystoscopy, and evaluation, significantly reducing diagnostic delays. 2.2 Center of Excellence Model Develop regional centers of excellence with multidisciplinary teams capable of providing rapid, coordinated care to GU cancer patients.3. Multidisciplinary Tumor Boards 3.1 Mandatory Case Discussions All GU cancer cases should be presented at regional MDT tumor boards before major treatment decisions. 3.2 Cross-Sector Collaboration Encourage private sector participation through MOUs and digital platforms. 3.3 Virtual Tumor Boards Utilize telemedicine platforms to allow cross-institutional participation, especially from remote areas.4. Insights from Bader Early Detection Program o Presented by Dr. Esam Murshid. o Ministry of Defense initiative covering 5.8 million people. o Early detection effective, but major delays exist in internal referrals. o 35% of diagnosed patients fail to access definitive treatment promptly. o Insurance authorizations and internal bottlenecks identified as obstacles. o Emphasized that early detection must be coupled with efficient care pathways.4. Insights from Bader Early Detection Program o Presented by Dr. Esam Murshid. o Ministry of Defense initiative covering 5.8 million people. o Early detection effective, but major delays exist in internal referrals. o 35% of diagnosed patients fail to access definitive treatment promptly. o Insurance authorizations and internal bottlenecks identified as obstacles. o Emphasized that early detection must be coupled with efficient care pathways.5. Feasibility of National Change o An Advisor highlighted that real change requires MOH involvement. o Emphasized challenges in unifying practices across independent sectors. o Advocated for presenting data-driven recommendations to health authorities.6. Public and Physician Education Campaigns 6.1 Patient Awareness o Create short, culturally adapted educational videos and infographics. o Promote messages via SMS, WhatsApp, LinkedIn, and public campaigns. o Focus on hematuria as a potential early sign of cancer. 6.2 Primary Care Education o Conduct CME activities targeting family physicians and general urologists. o Disseminate quick-reference guidelines and pathways. o Integrate GU malignancy red flags into routine family medicine training.7. Digital Platforms 7.1 Website Development Launch an HCP-only educational platform with: o Best practices for diagnosis and referral o Downloadable checklists o Updated clinical guidelines and consensus statements